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Primary dural lymphoma (PDL) usually arises from the calvarial dura without the brain parenchyma or systemic involvement and
thus may not be considered as a typical form of primary CNS lymphoma (PCNSL). It is exceedingly rare. When it occurs, it might
not be suspected as a primary diagnosis on clinical and radiologic ﬁndings. We present a PDL case that occurs at the
cerebellopontine (CP) angle mimicking en plaque meningioma. The tumor histopathology showed a lymphoproliferative
disorder immunophenotypically consistent with a low-grade marginal zone lymphoma. Bone marrow and systemic
involvements were not identiﬁed, and a diagnosis of PDL was established. As a residual tumor at the CP angle was inaccessible
to surgery, postoperative radiation therapy was performed. No recurrence was found at 15-month follow-up. PDLs are mostly
indolent and have a good prognosis. There is no doubt that the most important diﬀerential diagnosis is meningioma.
Furthermore, the present case emphasizes the necessity of an intraoperative consultation and knowledge of this rare yet essential
form of PCNSL so that appropriate studies can be ordered.

1. Introduction
PCNSL is an extranodal non-Hodgkin lymphoma that commonly involves the brain, spinal cord, leptomeninges, and
ocular structures [1]. Dura involvement is typically secondary to the lesion in the brain parenchyma [2]. However,
PDL is extra-axial and arises from the dura in the absence
of systemic or brain parenchymal involvement [3]. Technically, it may not be best classiﬁed as PCNSL. PDL is in fact
extremely rare and only comprises less than 1% of PCNSL
[4]. A recent retrospective study of the database from Massachusetts General Hospital and Yale School of Medicine
shows that 20 out of 316 PCNSL patients are PDL [5]. PDL
usually presents as a low-grade marginal zone B-cell lymphoma, but other subtypes exist as well [5]. An extranodal
marginal zone lymphoma usually occurs in a variety of extranodal sites. When it involves the lung, gastrointestinal tract,
bladder, and lacrimal gland, it is known as a mucosaassociated lymphoid tissue lymphoma [6, 7]. Due to the fact
that the majority of PDLs are low-grade marginal zone B-cell

lymphomas, the prognosis tends to be much more favorable,
especially in comparison to bona ﬁde PCNSLs. Its clinical
and radiographic features mostly mimic meningioma so that
diagnosis of meningioma is often made clinically prior to the
pathological ﬁndings [8]. Given the accumulating reports for
the past decades, PDL histopathology is much more deﬁned.
Further exploration of variability of PDL would shed light on
its pathogenic mechanism.

2. Case Presentation
A 67-year-old female patient was initially seen for left-sided
facial and mouth numbness, watering eye, and altered taste,
which progressed over one year. MRI of the brain with and
without contrast revealed a 2:6 × 2:1 cm well-deﬁned homogeneously enhancing extra-axial dural-based mass at the left
CP angle, which extended superiorly to the tentorium, suspicious for en plaque meningioma (Figure 1). The patient was
admitted to the neurosurgery department and received surgical resection of the tumor. External beam radiation with a
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Figure 1: Post contrast MRI demonstrates a well-deﬁned
homogeneously enhancing extra-axial dural-based mass in the left
CP angle suspicious for an en plaque meningioma.

total of 36 Gy over 20 fractions was used for the residual
tumor, which was inaccessible at the CP angle during surgery. The histopathological analysis revealed a dense atypical
small to intermediate lymphocytic inﬁltrate with a focal
nodular pattern. Focal meningothelial cells demonstrated
by epithelial membrane antigen, progesterone receptor, and
somatostatin receptor 2a immunohistochemistry were primarily present at the periphery (Figure 2). Immunohistochemistry for CD68 and CD138 highlighted scattered
histiocytes and plasma cells and CD21 and CD23 for follicular dendritic cells. The atypical lymphocytes were positive for
CD20, PAX-5, and Bcl-2, but negative for CD5, CD10, Bcl-6,
CD1a, ALK, and cyclin D1. The Ki-67 proliferation index
was 20-30% (Figure 3). In situ hybridization to EpsteinBarr-encoded RNA was negative. Clonal rearrangements of
the immunoglobulin heavy chain and kappa light chain
genes were detected by PCR. These results were consistent
with B-cell lymphoproliferative disorder. Bone marrow aspiration biopsy and peripheral ﬂow cytometry were negative.
Clinically, no systemic lymphoma was identiﬁed. Cytogenetics demonstrated a normal karyotype. The patient was diagnosed with a primary dural low-grade extranodal marginal
zone B-cell lymphoma. She was in remission without
recurrence at the 15-month follow-up.

3. Discussion
PDLs grow from the dura without the brain parenchymal or
systemic involvement. The lymphomas inﬁltrate meningeal
tissue, which often presents with sclerotic features. Most of
PDLs arise from the calvarial dura. According to Karschnia
et al., 55% are from the calvarial dura, 30% from the skull
base, and 15% from the spinal dura out of 20 PDL cases in
the database [5]. They rarely occur at the CP angle. This case
showed an extra-axial dural-based mass at the left CP angle.
The tumor extended superiorly to the tentorium and resulted
in trigeminal nerve palsy. It was not completely accessible to
surgery, so that postoperative radiation therapy was performed in the surgical bed. The majority of PDLs are low-

(b)

Figure 2: (a) Routine H&E stain demonstrates peripheral scattered
meningothelial cells. (b) These meningothelial cells are highlighted
by somatostatin receptor 2a immunohistochemistry.

grade marginal zone B-cell lymphomas [5, 9]. They respond
well to radiation and tend to have indolent clinical courses [3,
10]. This is quite consistent with marginal zone B-cell lymphomas in other sites, such as the stomach and thyroid
[10]. Although local and systemic relapses can occur, they
still respond to subsequent treatment [9]. Immunohistochemical analysis of PDLs often reveals features of marginal
zone B-cells, e.g., CD20+, CD5-, CD10-, and Bcl-2+, that
help to distinguish them from follicular B-cells. PDLs frequently present similar clinical features and neuroimaging
ﬁndings to meningioma, such as age of onset and higher
occurrence in women and isointense extra-axial masses on
radiographs. Therefore, histopathological analysis is critical
for PDL diagnosis.
PDL is rare and usually has a diﬀerent prognosis from
PCNSL. Surgical excision has been established as the standard treatment for the past decades. However, complete
resection could be a challenge if PDL presents as an inﬁltrative and/or en plaque lesion. Adjuvant treatment with either
radiation or chemotherapy is then indicated. In this case,
postoperative external beam radiation to the residual tumor
allowed complete remission. Since recurrence can develop
after complete remission following the initial treatment,
regular follow-up is highly recommended [9]. Although
most of cerebral PDLs are low-grade marginal zone B-cell
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Figure 3: (a) Routine H&E stain demonstrates the atypical lymphocytes. These lymphocytes are positive for CD20 (b) with increased Ki-67
proliferation index (c).

lymphomas, other subtypes, including diﬀuse large B-cell,
follicular, T-cell non-Hodgkin, and B-cell small lymphocytic
lymphomas, have been reported [5, 11]. Spinal PDLs, however, are frequently diﬀuse large B-cell lymphomas [12]. So
far, no deﬁnitive adjuvant treatment is established for all
subtypes. Unquestionably, a large database is needed to
explore the signiﬁcant association between the treatment
options and their clinical outcomes that appear to be well
based on the published data so far and likewise in this case.
Besides, investigation of pathogenic development of PDLs
might lead to novel therapeutic approaches.
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